Gene · 80331
Papers3,340
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,461 to 1,480 of 3,340
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The contribution of multicellular model organisms to neuronal ceroid lipofuscinosis research. | Biochim Biophys Acta Mol Basis Dis | 2020 | 31783156 | PubTator, text mining | PubMed |
| Integrated Cross-Sectional Multiplex Serosurveillance of IgG Antibody Responses to Parasitic Diseases and Vaccines in Coastal Kenya. | Am J Trop Med Hyg | 2020 | 31769388 | PubTator, text mining | PubMed |
| Preclinical Development and Assessment of Viral Vectors Expressing a Fusion Antigen of Plasmodium falciparum LSA1 and LSAP2 for Efficacy against Liver-Stage Malaria. | Infect Immun | 2020 | 31740525 | PubTator, text mining | PubMed |
| Characterizing Post-Translational Modifications and Their Effects on Protein Conformation Using NMR Spectroscopy. | Biochemistry | 2020 | 31682116 | PubTator, text mining | PubMed |
| Mechanisms of secretion and spreading of pathological tau protein. | Cell Mol Life Sci | 2020 | 31667556 | PubTator, text mining | PubMed |
| Immune Signature Against Plasmodium falciparum Antigens Predicts Clinical Immunity in Distinct Malaria Endemic Communities. | Mol Cell Proteomics | 2020 | 31658979 | PubTator, text mining | PubMed |
| Fast and fierce versus slow and smooth: Heterogeneity in immune responses to Plasmodium in the controlled human malaria infection model. | Immunol Rev | 2020 | 31605396 | PubTator, text mining | PubMed |
| Combining immunoprofiling with machine learning to assess the effects of adjuvant formulation on human vaccine-induced immunity. | Hum Vaccin Immunother | 2020 | 31589550 | PubTator, text mining | PubMed |
| Complement in malaria immunity and vaccines. | Immunol Rev | 2020 | 31556468 | PubTator, text mining | PubMed |
| Highlights of ASS234: a novel and promising therapeutic agent for Alzheimer's disease therapy. | Neural Regen Res | 2020 | 31535639 | PubTator, text mining | PubMed |
| Decrease in MiR-148a Expression During Initiation of Chief Cell Transdifferentiation. | Cell Mol Gastroenterol Hepatol | 2020 | 31473306 | PubTator, text mining | PubMed |
| Evaluation of Hemodynamic Changes in Fetuses With Isolated Mild-to-Moderate Ventriculomegaly by Transabdominal Ultrasound. | J Ultrasound Med | 2020 | 31448445 | PubTator, text mining | PubMed |
Combining antimalarial drugs and vaccine for malaria elimination campaigns: a randomized safety and immunogenicity trial of RTS,S/AS01 administered with dihydroartemisinin, piperaquine, and primaquine in healthy Thai adult volunteers. | Hum Vaccin Immunother | 2020 | 31306084 | PubTator, text mining | PubMed |
| Immune escape and immune camouflage may reduce the efficacy of RTS,S vaccine in Malawi. | Hum Vaccin Immunother | 2020 | 30614773 | PubTator, text mining | PubMed |
| Successful Vaccines. | Curr Top Microbiol Immunol | 2020 | 30046984 | PubTator, text mining | PubMed |
| Dual targeting of folate receptor-expressing glioma tumor-associated macrophages and epithelial cells in the brain using a carbon nanosphere-cationic folate nanoconjugate. | Nanoscale Adv | 2019 | 36133563 | PubTator, text mining | PubMed |
| Advances in the Treatment of Neuronal Ceroid Lipofuscinosis. | Expert Opin Orphan Drugs | 2019 | 33365208 | PubTator, text mining | PubMed |
| Checkpoint Inhibitor Immunotherapy for Head and Neck Cancer: Incorporating Care Step Pathways for Effective Side-Effect Management. | J Adv Pract Oncol | 2019 | 33014516 | PubTator, text mining | PubMed |
| Putative circumsporozoite protein (CSP) of Plasmodium vivax is considerably distinct from the well-known CSP and plays a role in the protein ubiquitination pathway. | Gene X | 2019 | 32550551 | PubTator, text mining | PubMed |
| Detection of EXP1-Specific CD4+ T Cell Responses Directed Against a Broad Range of Epitopes Including Two Promiscuous MHC Class II Binders During Acute Plasmodium falciparum Malaria. | Front Immunol | 2019 | 32038611 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/80331/papers?page=74